WO2007147404A3 - Composition pharmaceutique contenant un polyanion extracellulaire d'arthrospires - Google Patents

Composition pharmaceutique contenant un polyanion extracellulaire d'arthrospires Download PDF

Info

Publication number
WO2007147404A3
WO2007147404A3 PCT/DE2007/001110 DE2007001110W WO2007147404A3 WO 2007147404 A3 WO2007147404 A3 WO 2007147404A3 DE 2007001110 W DE2007001110 W DE 2007001110W WO 2007147404 A3 WO2007147404 A3 WO 2007147404A3
Authority
WO
WIPO (PCT)
Prior art keywords
arthrospira
pharmaceutical composition
polyanion
extracellular
polyanionic polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2007/001110
Other languages
German (de)
English (en)
Other versions
WO2007147404A2 (fr
Inventor
Christian Walter
Tanja Koenig
Rainer Buchholz
Stefanie Thulke
Manfred Marschall
Berit Smestad Paulsen
Andreas Nitsche
Sabine Rechter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2007147404A2 publication Critical patent/WO2007147404A2/fr
Publication of WO2007147404A3 publication Critical patent/WO2007147404A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne une composition pharmaceutique, destinée à la prévention et/ou au traitement d'infections virales, qui contient une dose physiologiquement efficace d'un polysaccharide polyanionique ou d'un de ses sels. Ce polysaccharide polyanionique est obtenu par extraction d'un surnageant de culture d'arthrospires. L'invention concerne en outre un procédé pour la préparer.
PCT/DE2007/001110 2006-06-21 2007-06-20 Composition pharmaceutique contenant un polyanion extracellulaire d'arthrospires Ceased WO2007147404A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006029448A DE102006029448A1 (de) 2006-06-21 2006-06-21 Pharmazeutische Zusammensetzung mit einem extrazellulären Polyanion aus Arthrospira
DE102006029448.3 2006-06-21

Publications (2)

Publication Number Publication Date
WO2007147404A2 WO2007147404A2 (fr) 2007-12-27
WO2007147404A3 true WO2007147404A3 (fr) 2008-11-20

Family

ID=38721235

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2007/001110 Ceased WO2007147404A2 (fr) 2006-06-21 2007-06-20 Composition pharmaceutique contenant un polyanion extracellulaire d'arthrospires

Country Status (2)

Country Link
DE (1) DE102006029448A1 (fr)
WO (1) WO2007147404A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201932132A (zh) * 2017-11-17 2019-08-16 遠東生物科技股份有限公司 藍綠藻生物質於治療b型肝炎病毒感染之用途
WO2020036869A1 (fr) 2018-08-16 2020-02-20 Emd Millipore Corporation Dispositif de biotraitement fermé
CN119523915B (zh) * 2024-12-31 2026-01-02 浙江康牧药业有限公司 一种氟苯尼考复合药物的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585365A (en) * 1993-07-27 1996-12-17 Nippon Oil Co., Ltd. Antiviral polysaccharide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585365A (en) * 1993-07-27 1996-12-17 Nippon Oil Co., Ltd. Antiviral polysaccharide

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DE PHILIPPIS ROBERTO ET AL: "Exocellular polysaccharides from cyanobacteria and their possible applications", FEMS MICROBIOLOGY REVIEWS, vol. 22, no. 3, September 1998 (1998-09-01), pages 151 - 175, XP002493567, ISSN: 0168-6445 *
NICOLAUS B ET AL: "Chemical composition and production of exopolysaccharides from representative members of heterocystous and non-heterocystous cyanobacteria", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 52, no. 4, 1 October 1999 (1999-10-01), pages 639 - 647, XP004291049, ISSN: 0031-9422 *
TSENG CHAO-TSI ET AL: "Extraction, purification and identification of polysaccharides of Spirulina (Arthrospira) platensis (Cyanophyceae)", ARCHIV FUER HYDROBIOLOGIE SUPPLEMENTBAND, vol. 105, no. 0, 1994, pages 303 - 312, XP009104964, ISSN: 0342-1120 *
ZHENG W ET AL: "Oral administration of exopolysaccharide from Aphanothece halophytica (Chroococcales) significantly inhibits influenza virus (H1N1)-induced pneumonia in mice", INTERNATIONAL IMMUNOPHARMACOLOGY 200607 NL, vol. 6, no. 7, 28 February 2006 (2006-02-28), pages 1093 - 1099, XP002493566, ISSN: 1567-5769 *

Also Published As

Publication number Publication date
WO2007147404A2 (fr) 2007-12-27
DE102006029448A1 (de) 2007-12-27

Similar Documents

Publication Publication Date Title
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2014018596A3 (fr) Alpha (1,2) fucosyltransférases appropriées pour une utilisation dans la production d'oligosaccharides fucosylés
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2012024620A3 (fr) Inhibiteurs de l'autotaxine et leurs utilisations
CL2012001336A1 (es) Composicion farmaceutica solida de daptomicina preparada por liofilizacion de una solucion acuosa que comprende daptomicina y al menos un excipiente seleccionado de glicina y un azucar no reductor con un ph de 6,5-7,5; producto farmaceutico; metodo de fabricacion; uso para tratar infecciones bacterianas.
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
WO2012088266A3 (fr) Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3
EP4327867A3 (fr) Composition pharmaceutique comprenant des dérivés de glucopyranosyldiphénylméthane, forme pharmaceutique correspondante, procédé pour leur préparation et utilisations
WO2009062112A3 (fr) Utilisation d'inhibiteurs de récepteurs tam en tant qu'antimicrobiens
HK1203357A1 (en) Fibroblast growth factor 21 proteins
WO2011159067A3 (fr) Dérivés de thiazole en tant qu'inhibiteurs de sglt2 et composition pharmaceutique comprenant ceux-ci
WO2009024677A3 (fr) Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
WO2012009715A3 (fr) Nouveaux dérivés de la cyclosporine destinés à traiter et à prévenir une infection virale
WO2012093234A3 (fr) Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2007126363A8 (fr) Nouvelle approche du traitement du syndrome du compartiment
WO2011035335A3 (fr) Compositions d'adamts13 liquides stabilisées et lyophilisées
WO2012017323A3 (fr) Composition pharmaceutique et méthodes de traitement et de prévention des maladies provoquées par le vih ou associées au vih
WO2012057575A3 (fr) Composition de supplément alimentaire comprenant des extraits de curcuma et de stevia en tant que principes actifs destinée à accroître la résistance aux virus de la maladie des points blancs, et composition alimentaire le comprenant
BRPI1010948A2 (pt) Composição compreendendo pelo menos trans- cinamaldeído e a respectiva utilização no tratamento das infecções bacterianas, mais particularmente no tratamento das doenças nosocomiais.
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
HK1217295A1 (zh) 4'-疊氮基，3'-脫氧基-3'-氟取代的核苷衍生物
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2011075606A3 (fr) Variants de polypeptide hyperglycosylé et procédés d'utilisation
WO2008042841A3 (fr) Compositions du docétaxel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07785544

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: RU

WWE Wipo information: entry into national phase

Ref document number: 2007785544

Country of ref document: EP

122 Ep: pct application non-entry in european phase

Ref document number: 07785544

Country of ref document: EP

Kind code of ref document: A2